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Thymic carcinoma is a rare malignant neoplasm. We present a Japanese case of papillary carcinoma of thymus in
a 64-year-old man that invaded into subcutaneous tissue penetrating the sternum. We describe the clinical and
pathologic features of this extremely rare thymic epithelial tumor, with disease-free survival at three years of follow-up.
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Thymic carcinoma is a rare tumor. The most common
histological subtype of thymic carcinoma is squamous
cell carcinoma, and adenocarcinoma is extremely rare.
We report the case of a 64-year-old Japanese man with
thymic papillary carcinoma. In this case, the tumor invaded
into subcutaneous tissue by penetrating the sternum with
osteolytic change.Case presentation
A 64-year-old Japanese man presented with bulging of
the anterior chest wall for 3 months duration. On exam-
ination, a round mass was palpable with tenderness and
redness, and fixed in the upper mid- sternum. The pa-
tient had undergone wedge resection of the right upper
lobe due to a spontaneous pneumothorax when he was
young. Computed tomographic (CT) scan showed a 7.5 ×
5.5 × 7.2 cm mass in anterior mediastinum invading
into subcutaneous fat tissue through the sternum with
bone destruction (Figure 1a and b). On fluorine-18-
fluorodeoxyglucose (FDG)-positron emission tomog-
raphy (PET), abnormal FDG uptake was observed only
in the mediastinal mass with a maximum standardized
uptake ratio of 15.0. Serum carcinoembryonic antigen* Correspondence: okami-ji@mc.pref.osaka.jp
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other tumor markers (AFP, beta-HCG, SCC), anti-
acetylcholine receptor antibody, and an alkaline phos-
phatase were negative. The tumor was diagnosed to be
carcinoma by fine-needle aspiration, but the definitive
histology could not be determined.
The patients underwent enbloc resection of the tumor
through a midline incision over the sternum and a right
collar incision. The tissue around the tumor was mobilized
in a circumferential manner, and an upper half of the ster-
num including terminal 3–5 cm of the clavicle and the
upper three ribs on the right side, medial end of the left
clavicle, and adjacent subcutaneous tissue and the skin.
The great vessels and the pericardium were free from the
tumor. Because upper lobes of both lungs were adherent
to the mediastinal pleura at the tumor site, wedge resec-
tions were performed. Regional lymph node exploration
revealed no nodal involvement of the tumor cells. The
sternal defect was not reconstructed. The postoperative
course was uneventful and the patient was discharged on
the 14th day after surgery. Paradoxical respiratory move-
ment of the chest was not observed. Serum CEA level
returned to normal 3 months after surgery.
Macroscopic examination of the tumor penetrating
the sternum was not encapsulated but showed a vaguely
infiltrative border with extension into mediastinal tissue
and subcutaneous fat (Figure 2a). Histological examination
revealed that the tumor cells proliferate in papillary clus-
ters separated by fibrovascular septa (Figure 2b and c).d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The computed tomographic scan showed an anterior mediastinal tumor penetrating into the sternum. (a) Horizontal section;
(b) sagittal section.
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plasm. The nuclei of tumor cells are bizarrely shaped with
prominent nucleoli. Parietal involvement was positive, but
histological invasion of the tumor cell into pulmonary
parenchyma was not observed. The result of immuno-
histochemical investigations were that CEA was positive
but thyroglobulin, BER-EP4, CD56, chromogranin A,
and synaptophysin were negative. Based on these findings,
the primary thymic papillary adenocarcinoma was diag-
nosed. The disease was described at stage III (T3N0M0)
according to Weissferdt-Moran TNM Staging System
for Thymic Carcinoma [1] and also at the same stage by
Masaoka staging system for thymoma. Any adjuvant
therapy was performed for this patient because there is
no evidence-based treatment for thymic carcinoma after
the tumor is completely resected. The patient has been
free of disease for 36 months after surgery without any
other treatment.
Discussion
Thymic carcinoma is relatively uncommon among thymic
epithelial tumors, constituting approximately 10% of these
lesions [2]. While most of them are squamous cell carcin-
oma, papillary carcinoma, one of the subtypes of thymic
adenocarcinoma, is an exceedingly rare tumor and wasFigure 2 A gross specimen of the thymic tumor (a) and pathological
for b and x200 for c).first described in 1998 [3]. According to the histological
study of 65 patients with thymic carcinoma, papillary
carcinoma represents only 2 cases (3%) [4]. Recently,
two of the cases with papillary thymic adenocarcinoma
have been reported. One developed in a thymic cyst [5]
and the other one was incidentally found in the resected
specimen of type AB thymoma [6]. Contrary to the
thymus, the papillary morphology is common in other
organs. For differential diagnosis, the possibility of a
metastatic papillary carcinoma or a papillary carcin-
oma in an ectopic thyroid gland should be excluded. In
this case, following negative immunohistochemical stain-
ing for thyroglobulin and no subsequent malignant disease
after surgery, we have confirmed the diagnosis. The clin-
ical features and the treatment outcomes of thymic papil-
lary carcinoma have not been well described yet. The
limited available reports indicate that five out of eight
cases developed recurrences at local site or as pleural dis-
semination within 2 years of surgery [7]. The remarkable
elevation of serum CEA value, which was observed in this
case, did not seem to be common in papillary thymic car-
cinoma in the literature, while positive immunoreactivity
of this antigen was sporadically reported [3]. More cases
need to be accumulated to define the clinical features of
this type of thymic carcinoma.findings (Hematoxylin and eosin stain, original magnification x40
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case was characterized for the highly aggressive invasive-
ness to the sternum. The tumor destroyed the sternum
and the costal cartilages with osteolytic change and
reached subcutaneous fat tissue. Interestingly, any other
adjacent organs such as great vessels, pericardium, and
lung were not involved. As long as we searched similar
cases in the literature, there was a case with thymic carcin-
oma minimally invading into the sternum [8]. However, it
seemed to be rare that this disease represents the massive
sternal invasion as seen in this case.
Resection of the sternum often requires skeletal and/
or soft tissue reconstruction with artificial materials or a
muscle flap. We discussed this issue with a plastic surgeon
preoperatively and planed a pectoralis major muscle flap
for an anterior chest wall reconstruction if it was neces-
sary. Consequently, reconstruction was not indicated in
this patient because sufficient stability and rigidity of the
chest wall were maintained.
Conclusion
We described the clinical and pathologic features of this
extremely rare thymic papillary adenocarcinoma that in-
vaded into subcutaneous tissue penetrating the sternum.
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